Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia

Abstract

The occurrence of skeletal morbidity in ALL children may be influenced by age and the type of glucocorticoids. These findings may facilitate the development of effective bone protective intervention.